PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.10
ESG score 90-95% of Healthcare median of 62.76. John Neff would demand higher returns to compensate for below-average ESG risk management.
51.50
Environmental score 80-90% of Healthcare median of 58.99. Martin Whitman would look for hidden carbon liabilities and stranded asset risks.
59.70
Social score 90-95% of Healthcare median of 64.69. John Neff would demand higher returns to compensate for below-average stakeholder management.
60.10
Governance score 90-95% of Healthcare median of 63.53. John Neff would demand higher returns to compensate for below-average governance oversight.